6 hours ago
BBIO Stock Surges 16% As AstraZeneca-Ionis Heart Drug Trial Misses Goal — BofA Calls Failure ‘A Big Surprise’
AstraZeneca and Ionis announced on Thursday that their late-stage CARDIO-TTRansform trial for eplontersen (Wainua) failed to meet its main goal. Analysts largely viewed the miss as a significant blow to Ionis but not fatal for the company overall.... Read more.
Owner: David Córdova through Información y Participación S.L.
Owner: Chinese Government through The State Council of the People's Republic of China
Owner: Near East Media (Non-profit, Joel C. Rosenberg Founder & Editor in Chief)
More from Asianet Newsable
Owner: Rajeev Chandrasekhar through Jupiter Capital Pvt Ltd & Asianxt Digital Technologies Pty Ltd
Owner: Rajeev Chandrasekhar through Jupiter Capital Pvt Ltd & Asianxt Digital Technologies Pty Ltd
Owner: Rajeev Chandrasekhar through Jupiter Capital Pvt Ltd & Asianxt Digital Technologies Pty Ltd
Search & Explore
Search the news with more context, not more noise.
Today's Media Watch
Your daily guide to the stories shaping media, journalism, and public trust.
Who Owns the Narrative?
See the impact of media framing through real-world case studies.
The EU-Mercosur
Free-trade agreements divide opinion. The EU-Mercosur deal sparked conflicting headlines, reflecting debates over prices, industry, environment, and self-sufficiency.
COVID Vaccinations
This analysis of COVID vaccination coverage shows how ideology, ownership, and political framing shape media narratives, influencing both what we think and how we think.
Greenland
This case study explores the Greenland acquisition scenario as a real-world media literacy stress test, revealing how ideology, ownership, and political framing shape the stories we consume.
Learn About Our Fact-Based Transparency System
Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.
Learn more
